Form 4 Filing for Jones William A JR

This filing details the disposition of securities by Jones William A JR, a director at Apogee Therapeutics, Inc. On September 3, 2026, 34,824 shares of Common Stock were disposed of. Additionally, stock options to purchase 10,370, 14,461, and 7,657 shares of Common Stock were also disposed of. These transactions occurred pursuant to an Agreement and Plan of Merger. The options were vested at the time of the merger and were disposed of in exchange for a cash payment based on the merger consideration and the exercise price. All post-transaction share amounts are reported as zero, indicating the completion of these transactions.